Related Articles
Intravesical Erdafitinib (TAR-210) Demonstrates High Response Rates in NMIBC With Reduced Toxicity – Roger Li
Sam Chang engages with Roger Li to delve into the TAR-210 study, focusing on bladder-based intravesical therapy targeting FGFR3 in non-muscle invasive bladder cancer (NMIBC)…
Researchers identify connection between air pollutants and allergic diseases
A study by researchers at National Jewish Health published in the Annals of Allergy, Asthma & Immunology reports that air pollutants—including particulate matter, pollen, greenhouse…
Developing transmissible vaccines for animal infections
Intrinsically safe designs and a staged transparent development process will be essential
4 employment contract red flags young physicians should watch for
Young physicians are not usually well-versed in contract law. One AMA expert outlines some points to avoid in the physician employment contract.
SCOTUS to hear arguments on whether emergency care law preempts state abortion ban
The Supreme Court will hear oral arguments tomorrow morning in a case highlighting the clash between federal emergency care requirements and state laws banning abortion…
4 Years In, a Sobering Look at Long COVID Progress
Long COVID is still a disease diagnosed by figuring out what a patient does not have. Symptom management is the only treatment now.
‘Heat is on’ cross-market hospital merger oversight: researchers
Health systems that purchased hospitals at least 50 miles away increased prices by 12.9% relative to a control group, new research shows.
VIDEO: What physicians should know about diagnosing chronic diarrhea
BOSTON — Chronic diarrhea is an “incredibly common” condition, with about one out of 20 patients presenting with symptoms, according to Brian E. Lacy, MD,…
Immunotherapy Safely Boosted with Particle-Bound Cytokines in Tumor Models
Used in combination with immune checkpoint therapy, cytokine molecules “step on the gas” to jump-start the immune system’s anticancer response.